Hypertension, Vol 7, 443-446, Copyright © 1985 by American Heart Association
JR Ryan, W LaCorte, A Jain and FG McMahon
To evaluate the response during insulin-induced hypoglycemia, diabetics
treated with relatively selective or nonselective beta-adrenergic blocking
agents were studied. Placebo, atenolol (100 mg/day), and propranolol (80 mg
b.i.d.) were administered to 12 insulin-treated diabetics for 1 week in a
double-blind, randomized, crossover fashion with a 2-week washout between
treatments. Sufficient intravenous insulin (0.2-0.6 units/kg) was
administered to decrease plasma glucose 68% from the basal level or to less
than 60 mg/dl within 90 minutes. Blood pressure changes at the nadir of
plasma glucose were +15.2/-9.9 mm Hg for placebo, +27.9/0 mm Hg for
atenolol, and +38.8/+14.3 mm Hg for propranolol. Diastolic blood pressure
changes induced by propranolol were significantly different from those
induced by atenolol (p less than 0.01) and placebo (p less than 0.01), and
systolic pressure changes were significantly different (p less than 0.02)
between propranolol and atenolol. Mild seizures developed in two patients
treated with propranolol. Their blood pressure changes at the plasma
glucose nadir were +56/+22 and +86/+31 mm Hg. Other symptoms of
hypoglycemia were more frequent during beta-blocker than during placebo
treatment. Differences in response may be related to the relatively
selective adrenergic blocking effect of these drugs.
ARTICLES
Hypertension in hypoglycemic diabetics treated with beta-adrenergic antagonists
This article has been cited by other articles:
![]() |
J.M Cruickshank Beta-blockers continue to surprise us Eur. Heart J., March 1, 2000; 21(5): 354 - 364. [PDF] |
||||
![]() |
E. Grossman and F. H. Messerli High Blood Pressure: A Side Effect of Drugs, Poisons, and Food Arch Intern Med, March 13, 1995; 155(5): 450 - 460. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |